PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportseczema
MeSH D004485 - eczema
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D017443:Eczematous skin diseases
0 Companies
0 Drugs
Success rate
D003872:Dermatitis
56 Companies
27 Drugs
$
Success rate
D004485: 
Eczema
3 Companies
2 Drugs
$
Success rate
D011146:Dyshidrotic eczema
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%
0/1
Phase 2
5%
1/21
Phase 3
29%
12/41
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
Salicylic acid,
Docusate,
Vitamin e,
Ligelizumab,
Fevipiprant,
Ademetionine,
ADRIFORANT,
Corticoids,
CMK389,
Cee321,
DNK333
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use